Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| LABCORP HOLDINGS INC.LH · Entity 1277 | EVP and President, Diagnostics | September 01, 2026 | September 03, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
LABCORP HOLDINGS INC.
Report date September 01, 2026 · Filed September 03, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Restricted Stock UnitSEC Table II · derivative / convertible security | Direct | 5,204 |
Reported balance
After 2026-09-01 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2026-09-01 · Grant · Acquired 1,500 · Balance 5,204 F1: Each Restricted Stock Unit represents the contingent right to receive one share of Labcorp Holdings Inc. Common Stock. F2: The Restricted Stock Units vest in three equal annual installments beginning on September 1, 2027. F3: This number reflects the aggregate number of Restricted Stock Units held by the reporting person. |
Filing footnotes · ownership attribution and instrument terms
F1: Each Restricted Stock Unit represents the contingent right to receive one share of Labcorp Holdings Inc. Common Stock.
F2: The Restricted Stock Units vest in three equal annual installments beginning on September 1, 2027.
F3: This number reflects the aggregate number of Restricted Stock Units held by the reporting person.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| September 01, 2026 Filed Sep 3, 2026 12:18 UTC | LABCORP HOLDINGS INC. LH · Entity 1277 | GrantRestricted Stock Unit · Derivative | 1,500 | $0.00 | $0.00 |
DisclosureSEC source: 0000920148-26-000191 · form4.xml · derivative · entry 1 Vaughn Bryan T · CIK 0002103999 · EVP and President, Diagnostics 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,204 Underlying: Common Stock · 1,500 shares Expires not disclosed F1 · derivative.exercise_price: Each Restricted Stock Unit represents the contingent right to receive one share of Labcorp Holdings Inc. Common Stock. F2 · derivative.exercise_date: The Restricted Stock Units vest in three equal annual installments beginning on September 1, 2027. F2 · derivative.expiration_date: The Restricted Stock Units vest in three equal annual installments beginning on September 1, 2027. F3 · balance_after: This number reflects the aggregate number of Restricted Stock Units held by the reporting person. Read SEC document |
| July 02, 2026 Filed Jul 6, 2026 13:36 UTC | LABCORP HOLDINGS INC. LH · Entity 1277 | SaleCommon Stock | 234 | $286.19 | $66,968.46 |
DisclosureSEC source: 0000920148-26-000151 · form4.xml · nonDerivative · entry 3 Vaughn Bryan T · CIK 0002103999 · EVP and President, Diagnostics 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 6,745.5702 F3 · kind: Pursuant to a plan in accordance with Rule 10b5-1 under the Securities Exchange Act of 1934, as amended. Read SEC document |
| July 01, 2026 Filed Jul 6, 2026 13:36 UTC | LABCORP HOLDINGS INC. LH · Entity 1277 | Exercise / conversionRestricted Stock Unit · Derivative | 327 | $0.00 | $0.00 |
DisclosureSEC source: 0000920148-26-000151 · form4.xml · derivative · entry 4 Vaughn Bryan T · CIK 0002103999 · EVP and President, Diagnostics 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 3,704 Underlying: Common Stock · 327 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each Restricted Stock Unit represents the contingent right to receive one share of Labcorp Holdings Inc. Common Stock. F4 · derivative.exercise_date: The Restricted Stock Units that have vested were part of a grant that vests in three equal annual installments beginning on July 1, 2026. F4 · derivative.expiration_date: The Restricted Stock Units that have vested were part of a grant that vests in three equal annual installments beginning on July 1, 2026. F5 · balance_after: This number reflects the aggregate number of Restricted Stock Units held by the reporting person. Read SEC document |
| July 01, 2026 Filed Jul 6, 2026 13:36 UTC | LABCORP HOLDINGS INC. LH · Entity 1277 | Tax withholdingCommon Stock | 93 | $283.88 | $26,400.84 |
DisclosureSEC source: 0000920148-26-000151 · form4.xml · nonDerivative · entry 2 Vaughn Bryan T · CIK 0002103999 · EVP and President, Diagnostics 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 6,979.5702 F2 · kind: Stock withholding to satisfy tax withholding obligations. Read SEC document |
| July 01, 2026 Filed Jul 6, 2026 13:36 UTC | LABCORP HOLDINGS INC. LH · Entity 1277 | Exercise / conversionCommon Stock | 327 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000920148-26-000151 · form4.xml · nonDerivative · entry 1 Vaughn Bryan T · CIK 0002103999 · EVP and President, Diagnostics 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 7,072.5702 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each Restricted Stock Unit represents the contingent right to receive one share of Labcorp Holdings Inc. Common Stock. Read SEC document |
| March 26, 2026 Filed Mar 30, 2026 16:52 UTC | LABCORP HOLDINGS INC. LH · Entity 1277 | Tax withholdingCommon Stock | 451 | $268.38 | $121,039.38 |
DisclosureSEC source: 0000920148-26-000121 · form4.xml · nonDerivative · entry 2 Vaughn Bryan T · CIK 0002103999 · EVP, Diagnostics 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 6,745.5702 F2 · kind: Stock withholding to satisfy tax withholding obligations. Read SEC document |
| March 26, 2026 Filed Mar 30, 2026 16:52 UTC | LABCORP HOLDINGS INC. LH · Entity 1277 | GrantCommon Stock | 1,584 | $0.00 | $0.00 |
DisclosureSEC source: 0000920148-26-000121 · form4.xml · nonDerivative · entry 1 Vaughn Bryan T · CIK 0002103999 · EVP, Diagnostics 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 7,196.5702 F1 · kind: Shares acquired on March 26, 2026, pursuant to a performance award granted on February 7, 2023, relating to performance during the three-year period ended December 31, 2025. Read SEC document |
| February 11, 2026 Filed Feb 13, 2026 18:15 UTC | LABCORP HOLDINGS INC. LH · Entity 1277 | Exercise / conversionRestricted Stock Unit · Derivative | 323 | $0.00 | $0.00 |
DisclosureSEC source: 0000920148-26-000089 · form4.xml · derivative · entry 3 Vaughn Bryan T · CIK 0002103999 · EVP, Diagnostics 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,031 Underlying: Common Stock · 323 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each Restricted Stock Unit represents the contingent right to receive one share of Labcorp Holdings Inc. Common Stock. F3 · derivative.exercise_date: The Restricted Stock Units that have vested were part of a grant that vests in three equal annual installments beginning on February 11, 2026. F3 · derivative.expiration_date: The Restricted Stock Units that have vested were part of a grant that vests in three equal annual installments beginning on February 11, 2026. F4 · balance_after: This number reflects the aggregate number of Restricted Stock Units held by the reporting person. Read SEC document |
| February 11, 2026 Filed Feb 13, 2026 18:15 UTC | LABCORP HOLDINGS INC. LH · Entity 1277 | Tax withholdingCommon Stock | 93 | $289.89 | $26,959.77 |
DisclosureSEC source: 0000920148-26-000089 · form4.xml · nonDerivative · entry 2 Vaughn Bryan T · CIK 0002103999 · EVP, Diagnostics 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,612.5702 F2 · kind: Stock withholding to satisfy tax withholding obligations. Read SEC document |
| February 11, 2026 Filed Feb 13, 2026 18:15 UTC | LABCORP HOLDINGS INC. LH · Entity 1277 | Exercise / conversionCommon Stock | 323 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000920148-26-000089 · form4.xml · nonDerivative · entry 1 Vaughn Bryan T · CIK 0002103999 · EVP, Diagnostics 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,705.5702 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each Restricted Stock Unit represents the contingent right to receive one share of Labcorp Holdings Inc. Common Stock. Read SEC document |
| February 10, 2026 Filed Feb 12, 2026 20:42 UTC | LABCORP HOLDINGS INC. LH · Entity 1277 | GrantRestricted Stock Unit · Derivative | 730 | $0.00 | $0.00 |
DisclosureSEC source: 0000920148-26-000067 · form4.xml · derivative · entry 2 Vaughn Bryan T · CIK 0002103999 · EVP, Diagnostics 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,354 Underlying: Common Stock · 730 shares Expires not disclosed F3 · derivative.exercise_price: Each Restricted Stock Unit represents the contingent right to receive one share of Labcorp Holdings Inc. Common Stock. F4 · derivative.exercise_date: The Restricted Stock Units vest in three equal annual installments beginning on February 10, 2027. F4 · derivative.expiration_date: The Restricted Stock Units vest in three equal annual installments beginning on February 10, 2027. F5 · balance_after: This number reflects the aggregate number of Restricted Stock Units held by the reporting person. Read SEC document |
| February 10, 2026 Filed Feb 12, 2026 20:42 UTC | LABCORP HOLDINGS INC. LH · Entity 1277 | GrantNon-qualified Stock Options · Derivative | 2,200 | $0.00 Strike: $284.50 | $0.00 |
DisclosureSEC source: 0000920148-26-000067 · form4.xml · derivative · entry 1 Vaughn Bryan T · CIK 0002103999 · EVP, Diagnostics 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,200 Underlying: Common Stock · 2,200 shares Expires 2036-02-09 F1 · security: Employee stock option (right to buy) granted pursuant to the Labcorp Holdings Inc. 2025 Omnibus Incentive Plan. F2 · derivative.exercise_date: The option vests in three equal annual installments beginning on the date reflected in this column. Read SEC document |
| February 09, 2026 Filed Feb 10, 2026 20:05 UTC | LABCORP HOLDINGS INC. LH · Entity 1277 | Tax withholdingCommon Stock | 61 | $274.01 | $16,714.61 |
DisclosureSEC source: 0000920148-26-000027 · form4.xml · nonDerivative · entry 4 Vaughn Bryan T · CIK 0002103999 · EVP, Diagnostics 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,382.5702 F2 · kind: Stock withholding to satisfy tax withholding obligations. Read SEC document |
| February 07, 2026 Filed Feb 10, 2026 20:05 UTC | LABCORP HOLDINGS INC. LH · Entity 1277 | Exercise / conversionRestricted Stock Unit · Derivative | 178 | $0.00 | $0.00 |
DisclosureSEC source: 0000920148-26-000027 · form4.xml · derivative · entry 6 Vaughn Bryan T · CIK 0002103999 · EVP, Diagnostics 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,624 Underlying: Common Stock · 178 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each Restricted Stock Unit represents the contingent right to receive one share of Labcorp Holdings Inc. Common Stock. F5 · derivative.exercise_date: The Restricted Stock Units vested on February 7, 2026. F5 · derivative.expiration_date: The Restricted Stock Units vested on February 7, 2026. F4 · balance_after: This number reflects the aggregate number of Restricted Stock Units held by the reporting person. Read SEC document |
| February 07, 2026 Filed Feb 10, 2026 20:05 UTC | LABCORP HOLDINGS INC. LH · Entity 1277 | Exercise / conversionCommon Stock | 178 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000920148-26-000027 · form4.xml · nonDerivative · entry 3 Vaughn Bryan T · CIK 0002103999 · EVP, Diagnostics 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,443.5702 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each Restricted Stock Unit represents the contingent right to receive one share of Labcorp Holdings Inc. Common Stock. Read SEC document |
| February 06, 2026 Filed Feb 10, 2026 20:05 UTC | LABCORP HOLDINGS INC. LH · Entity 1277 | Exercise / conversionRestricted Stock Unit · Derivative | 180 | $0.00 | $0.00 |
DisclosureSEC source: 0000920148-26-000027 · form4.xml · derivative · entry 5 Vaughn Bryan T · CIK 0002103999 · EVP, Diagnostics 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,802 Underlying: Common Stock · 180 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each Restricted Stock Unit represents the contingent right to receive one share of Labcorp Holdings Inc. Common Stock. F3 · derivative.exercise_date: The Restricted Stock Units that have vested were part of a grant that vests in two equal annual installments beginning on February 6, 2026. F3 · derivative.expiration_date: The Restricted Stock Units that have vested were part of a grant that vests in two equal annual installments beginning on February 6, 2026. F4 · balance_after: This number reflects the aggregate number of Restricted Stock Units held by the reporting person. Read SEC document |
| February 06, 2026 Filed Feb 10, 2026 20:05 UTC | LABCORP HOLDINGS INC. LH · Entity 1277 | Tax withholdingCommon Stock | 61 | $277.20 | $16,909.20 |
DisclosureSEC source: 0000920148-26-000027 · form4.xml · nonDerivative · entry 2 Vaughn Bryan T · CIK 0002103999 · EVP, Diagnostics 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,265.5702 F2 · kind: Stock withholding to satisfy tax withholding obligations. Read SEC document |
| February 06, 2026 Filed Feb 10, 2026 20:05 UTC | LABCORP HOLDINGS INC. LH · Entity 1277 | Exercise / conversionCommon Stock | 180 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000920148-26-000027 · form4.xml · nonDerivative · entry 1 Vaughn Bryan T · CIK 0002103999 · EVP, Diagnostics 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,326.5702 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each Restricted Stock Unit represents the contingent right to receive one share of Labcorp Holdings Inc. Common Stock. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.